59 results on '"van der Bom, Johanna G."'
Search Results
2. Umbilical Cord Blood as an Alternative to Neonatal Blood for Complete Blood Count: A Comparison Study
3. Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis
4. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies
5. Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy
6. Patients’ and health care providers’ perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview study
7. Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients
8. In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype
9. Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease
10. SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
11. Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study
12. Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis
13. Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study
14. Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study
15. Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set
16. Biological stratification of clinical disease courses in childhood immune thrombocytopenia
17. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018
18. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia
19. The factor VIII treatment history of non‐severe hemophilia A
20. ADAMTS‐13 and bleeding phenotype in von Willebrand disease
21. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death
22. Predictive value of a bleeding score for postpartum hemorrhage
23. Additional Strategies to Minimize Blood Loss in Babies Born Very Preterm
24. Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study
25. Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
26. Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An Assessment of Postoperative Outcome Including Patients Refusing Blood Transfusion
27. von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
28. Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
29. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
30. Association Vs Causality in Transfusion Medicine: Understanding Multivariable Analysis in Prediction Vs Etiologic Research
31. Storage Time of Red Blood Cells and Mortality of Transfusion Recipients
32. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn
33. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
34. Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study)
35. Social participation of patients with hemophilia in the Netherlands
36. The Relationship between Low Von Willebrand Factor, Type 1 Von Willebrand Disease and Ageing - Novel Insights from the Lovic and Win Cohort Studies
37. Age Regulates Desmopressin Responses in Patients with Low Von Willebrand Factor and Type 1 Von Willebrand Disease in the Lovic and Win Studies
38. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study
39. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study
40. Bleeding in carriers of hemophilia
41. Thirty years of hemophilia treatment in the Netherlands, 1972-2001
42. Functional tasks exercise versus resistance exercise to improve daily function in older women: A feasibility study
43. Colorectal Cancer Screening in Patients with Inherited Bleeding Disorders: High Cancer Detection Rate in Hemophilia Patients
44. The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1
45. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia
46. Semiautomatic VWF Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
47. Genetic Association Studies of Red Blood Cell Transfusion Related Alloimmunization: A Systematic Review and Meta-Analysis
48. A Clinical Prediction Score for Course of Disease in Newly Diagnosed Childhood Immune Thrombocytopenia
49. Identification of Self-Limiting Pediatric Immune Thrombocytopenia at Diagnosis
50. Determinants of transfusion decisions in the intensive care unit: hemoglobin concentration: What else?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.